ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

June 11, 2014

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010

Editorial: Ambiance Through Exclusion

May 20, 1994

Harvard’s Harvey Fineberg Is Elected IOM President.

November 16, 2001

Rall Supports Animal Tests; Carcinogenesis Reports Summarized

May 13, 1977

In Brief: George Burton Retires After 23 Years At NCI; MDA Names Bodey Head Of Medical Specialists

February 20, 1987